ReviewJournal of enzyme inhibition and medicinal chemistry2026

PROTACs in cancer therapy: targeted degradation of GPX4, PARP and epigenetic regulators.

Sunny Periyasamy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.